← Open Payments lookup

JACK KACZMARCZYK: Open Payments

NPI 1427752401 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,609 in 172 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $826 · 2025 $2,609

Food & beverage: $2,602Education: $8
CompanyPaymentsAmount
ABBVIE INC.35$415
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$332
Neurocrine BioSciences, Inc.22$307
Supernus Pharmaceuticals, Inc.23$245
Otsuka America Pharmaceutical, Inc.12$224
Axsome Therapeutics, Inc.6$204
Vanda Pharmaceuticals Inc.12$194
E.R. Squibb & Sons, L.L.C.7$167
Teva Pharmaceuticals USA, Inc.15$154
Alkermes, Inc.9$147

Products named: VRAYLAR, CAPLYTA, INGREZZA, Qelbree, Auvelity, COBENFY, FANAPT, AUSTEDO XR.

Industry payments across MI — which companies pay providers there.